HHS Nominee Leavitt Says He Will Maintain FDA "Brand" Integrity
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA, NIH and CDC are the three HHS "brands" that act as a seal of quality, safety and good research, Michael Leavitt tells Senate Health confirmation hearing Jan. 18. FDA's goal must be to "inform consumers about risks and benefits," he says.